|
| Press Releases |
|
 |
|
| Monday, October 13, 2025 |
|
|
Kangji Medical and Knight Bidco Jointly Dispatch Scheme Document for Privatisation Proposal |
| Kangji Medical Holdings Limited ('Kangji Medical' or the 'Company', Stock Code: 9997.HK) and Knight Bidco Limited (the 'Offeror') today announced that a circular in relation to the proposed privatisation of Kangji Medical (the 'Scheme Document') has been published, setting out the terms and conditions of the proposed privatisation of Kangji Medical (the 'Proposal') by way of a scheme of arrangement. more info >> |
|
|
康基醫療與Knight Bidco聯合發佈私有化建議計劃文件 |
| 康基醫療控股有限公司（「康基醫療」或「公司」，股份代號：9997.HK）與Knight Bidco Limited（「要約人」）今日宣佈刊發有關建議私有化康基醫療的通函（「計劃文件」），當中載列通過協議安排方式對康基醫療進行擬議私有化（「建議」）的條款及條件。 more info >> |
|
|
康基医疗与Knight Bidco联合发布私有化建议计划文件 |
| 康基医疗控股有限公司（「康基医疗」或「公司」，股份代号：9997. HK）与Knight Bidco Limited（「要约人」）今日宣布刊发有关建议私有化康基医疗的通函（「计划文件」），当中载列通过协议安排方式对康基医疗进行拟议私有化（「建议」）的条款及条件。 more info >> |
|
| Wednesday, August 13, 2025 |
|
|
Kangji Medical Receives Privatisation Proposal from a Consortium Led by Kangji Medical's Chairman, Zhong Ming, TPG and QIA to Advance Long-Term Strategic Vision |
| Kangji Medical Holdings Limited ('Kangji Medical' or the 'Company', Stock Code: 9997.HK) and ''Knight Bidco Limited (the 'Offeror') today jointly announced a privatisation proposal. The parties intend to implement the privatisation of the Company by way of a ''scheme of arrangement'', with a view to enabling the Company to focus on long-term strategic decisions, such as longer-term business investment in R&D and operations enhancements. more info >> |
|
|
康基醫療收到由董事長鍾鳴、TPG及卡塔爾投資局(QIA)牽頭財團提出之私有化要約 助力公司實現長遠願景 |
| 康基醫療控股有限公司（「康基醫療」或「公司」，股份代號：9997.HK）與KNIGHT BIDCO LIMITED「要約人」今日聯合宣佈，雙方擬以協議安排的方式對公司進行私有化，以期公司能夠專注於長期戰略決策，包括研發長期投入及運營升級。 more info >> |
|
|
康基医疗收到由董事长钟鸣、TPG及卡塔尔投资局(QIA)牵头财团提出的私有化要约 助力公司实现长远愿景 |
| 康基医疗控股有限公司（"康基医疗"或"公司"，股份代号：9997.HK）与KNIGHT BIDCO LIMITED"要约人"今日联合宣布，双方拟以协议安排的方式对公司进行私有化，以期公司能够专注于长期战略决策，包括研发长期投入及运营升级。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
TOYOTA、ハイエース（バン・ワゴン・コミューター）を一部改良
Jan 13, 2026 13:50: JST
|
|
|
Honda四輪事業のシンボルに新たな「Hマーク」を採用
Jan 13, 2026 13:50: JST
|
|
|
'Power Women' shaping Asia's tomorrow's cities honoured at ARES 2025 VIP celebration
Jan 13, 2026 12:00 HKT/SGT
|
|
|
Australia Developers Triumph at the 20th PropertyGuru Asia Property Awards Grand Final
Jan 13, 2026 12:00 HKT/SGT
|
|
|
Assembly Unifies APAC Network Under One Brand to Build Asia's Leading Tech-Powered Brand Performance Agency
Jan 13, 2026 11:00: JST
|
|
|
アセンブリー、アジア太平洋地域ネットワークを単一ブランドに統合し、アジアを代表するテクノロジー駆動型ブランドパフォーマンスエージェンシーを構築
Jan 13, 2026 11:00: JST
|
|
|
Honda to Adopt New "H mark" as Symbol of Honda Automobile Business
Jan 13, 2026 11:26 JST
|
|
|
Assembly Unifies APAC Network Under One Brand to Build Asia's Leading Tech-Powered Brand Performance Agency
Jan 13, 2026 10:00 HKT/SGT
|
|
|
Eisai and Nuvation Bio Enter into Exclusive Licensing Agreement for Taletrectinib in Europe and Additional Countries Outside the U.S., China and Japan
Jan 13, 2026 9:50 JST
|
|
|
德國透過北約支援與採購局採購八架MQ-9B海衛士(R)無人機
Jan 13, 2026 07:00 HKT/SGT
|
|
|
德国通过北约支持与采购局采购八架MQ-9B海卫士无人机
Jan 13, 2026 07:00 HKT/SGT
|
|
|
Germany Buys Eight MQ-9B SeaGuardian(R) RPA Through NSPA
Jan 13, 2026 07:00 HKT/SGT
|
|
|
OBIファーマとTegMine Therapeutics、糖鎖標的ADCに関する独占的グローバルライセンス契約を締結
Jan 12, 2026 21:00: JST
|
|
|
浩鼎與 TegMine Therapeutics簽訂醣標靶ADC 全球商業授權合約
Jan 12, 2026 20:00 HKT/SGT
|
|
|
浩鼎与 TegMine Therapeutics 签订醣靶标 ADC 全球商业授权合约
Jan 12, 2026 20:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
